IBRX logo

ImmunityBio (IBRX) Operating Profit

Annual Operating Profit

-$361.36 M
-$10.75 M-3.07%

December 31, 2023


Summary


Performance

IBRX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIBRXprofitabilitymetrics:

Quarterly Operating Profit

-$80.25 M
+$19.08 M+19.21%

September 30, 2024


Summary


Performance

IBRX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIBRXprofitabilitymetrics:

TTM Operating Profit

-$359.29 M
-$117.00 K-0.03%

September 30, 2024


Summary


Performance

IBRX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIBRXprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

IBRX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.1%+19.2%-0.0%
3 y3 years-71.9%+5.8%+3.4%
5 y5 years-131.3%+5.8%+3.4%

IBRX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.4%at low-1.2%+28.1%-8.8%+3.4%
5 y5-year-131.3%at low-118.7%+28.1%-878.9%+3.4%
alltimeall time-131.3%at low-118.7%+28.1%-878.9%+3.4%

ImmunityBio Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$80.25 M(-19.2%)
-$359.29 M(+0.0%)
Jun 2024
-
-$99.33 M(+4.3%)
-$359.17 M(+4.1%)
Mar 2024
-
-$95.20 M(+12.7%)
-$344.98 M(-4.5%)
Dec 2023
-$361.36 M(+3.1%)
-$84.50 M(+5.4%)
-$361.36 M(+0.1%)
Sep 2023
-
-$80.14 M(-5.9%)
-$361.08 M(-2.9%)
Jun 2023
-
-$85.14 M(-23.7%)
-$371.75 M(+1.5%)
Mar 2023
-
-$111.58 M(+32.5%)
-$366.23 M(+4.5%)
Dec 2022
-$350.62 M
-$84.22 M(-7.3%)
-$350.62 M(+1.4%)
Sep 2022
-
-$90.80 M(+14.0%)
-$345.67 M(+3.6%)
Jun 2022
-
-$79.62 M(-17.0%)
-$333.70 M(-1.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$95.97 M(+21.1%)
-$339.99 M(+2.9%)
Dec 2021
-$330.28 M(+57.1%)
-$79.27 M(+0.6%)
-$330.28 M(+3.7%)
Sep 2021
-
-$78.84 M(-8.2%)
-$318.39 M(+8.0%)
Jun 2021
-
-$85.91 M(-0.4%)
-$294.77 M(+13.5%)
Mar 2021
-
-$86.26 M(+28.0%)
-$259.78 M(+23.6%)
Dec 2020
-$210.22 M(+34.5%)
-$67.39 M(+22.0%)
-$210.22 M(+47.2%)
Sep 2020
-
-$55.22 M(+8.4%)
-$142.84 M(+63.0%)
Jun 2020
-
-$50.92 M(+38.7%)
-$87.62 M(+138.7%)
Mar 2020
-
-$36.70 M
-$36.70 M
Dec 2019
-$156.25 M
-
-

FAQ

  • What is ImmunityBio annual operating income?
  • What is the all time high annual operating profit for ImmunityBio?
  • What is ImmunityBio annual operating profit year-on-year change?
  • What is ImmunityBio quarterly operating income?
  • What is the all time high quarterly operating profit for ImmunityBio?
  • What is ImmunityBio quarterly operating profit year-on-year change?
  • What is ImmunityBio TTM operating income?
  • What is the all time high TTM operating profit for ImmunityBio?
  • What is ImmunityBio TTM operating profit year-on-year change?

What is ImmunityBio annual operating income?

The current annual operating profit of IBRX is -$361.36 M

What is the all time high annual operating profit for ImmunityBio?

ImmunityBio all-time high annual operating income is -$156.25 M

What is ImmunityBio annual operating profit year-on-year change?

Over the past year, IBRX annual operating income has changed by -$10.75 M (-3.07%)

What is ImmunityBio quarterly operating income?

The current quarterly operating profit of IBRX is -$80.25 M

What is the all time high quarterly operating profit for ImmunityBio?

ImmunityBio all-time high quarterly operating income is -$36.70 M

What is ImmunityBio quarterly operating profit year-on-year change?

Over the past year, IBRX quarterly operating income has changed by +$19.08 M (+19.21%)

What is ImmunityBio TTM operating income?

The current TTM operating profit of IBRX is -$359.29 M

What is the all time high TTM operating profit for ImmunityBio?

ImmunityBio all-time high TTM operating income is -$36.70 M

What is ImmunityBio TTM operating profit year-on-year change?

Over the past year, IBRX TTM operating income has changed by -$117.00 K (-0.03%)